A prospective and comparative study between pre and post intra-articular knee injection to evaluate the efficacy of sodium hyaluronate (Hyruan®III) in the treatment of knee osteoarthritis
Keywords:
Sodium hyaluronic acid, knee osteoarthritis, intra-articular single injectionAbstract
Background: Many reports of sodium hyaluronate intra-articular injections into the knee joint show evidence of improvements of pain and function in osteoarthritis knees. Most of the injection techniques were a single dose once a week for 3 or 5 weeks according to each manufactures’ recomendation. Some manufactures prepared this for one single dose, one injection.
Objective: To elucidate a technique of three-in-one single doses of the intra-articular injection of sodium hyaluronate for osteoarthritis of the knee with regards to its safety and clinical outcomes between pre and post injection.
Methods: We combined three intra-articular injections of the high molecular weight sodium hyaluronate into a single dose to be administered as one single intra-articular injection to treat 100 osteoarthritis knees who failed the medical conservative treatment and physical therapy. The Visual Analogue Scale (VAS), Western Ontario and McMaster Universities Osteoarthritis (WOMAC) score, Knee Society score, and knee function score were the measurement methods. The mean difference between pre and post intra-articular injections in each efficacy score was compared and the safety of the injection was the main principle of evaluation.
Results: Ten knees were excluded due to not fulfilling the criteria. Only 90 knees were included. Using the Ahlback knee grading system, 60 knees were of grade I, 15 knees were of grade II, and 15 knees were of grade III. The average 100 mm VAS scale before injection was 44.26 and was reduced to its lowest point 7.41 at the 8th month follow up(P = 0.008), and increased to 36.85 at the 8th month after treatment. WOMAC scores were reduced to their lowest point 7.51at 8th month follow up (P = 0.011), and increased after 8 months after treatment to 36.75, therefore the VAS scale and WOMAC score decreased significantly. The average Knee Society score was 64.23 before injection and was raised to an average of 78.82 by the first month after injection (P = 0.002). At the 8th month after injection, the value was raised up to 90.20 (P=0.001). The average knee function score was 60.61 before injection. But after the first month post-injection, the average score was raised to 77.22, (P = 0.018). At the 8th month after injection, the value was 86.28(P = 0.001), therefore the knee score and functional score increased significantly.
Conclusion: The combined three to one single dose (high molecular weight) sodium hyaluronate (Hyruan®III) injection yielded high potency of clinical results comparing between pre and post injection in all indicators in this study.
Metrics
References
American College of Rheumatology (ACR). American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the Medical Management of Osteoarthritis of the Hip and Knee. Arthritis and Rheumatism. 2000; 43:1905-1915.
Mazieres B, Bannwarth B, Dougados M, Lequesne M. EULAR recommendations for the management of knee osteoarthritis: report of a taskforce of the Stand- ing Committee for International Clinical Studies In- cluding Therapeutic Trials. Joint Bone Spine. 2001; 68:231-240.
Raynauld J, Buckland-Wright C, Ward R, Choquette D, Haraoui B, Martel-Pelletier J, et al. Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee. Arth Rheum 2003; 48: 370–7
Dieppe PA, Sathapatayavongs B, Jones HE, Bacon PA, Ring EF. Intra-articular steroids in osteoarthritis. Rheumatol Rehabil 1980; 19: 212–7.
Smith MD, Wetherall M, Darby T, Esterman A, Slavotinek J, Robert-Thomson P, et al. A randomized placebo-controlled trial of arthroscopic lavage versus lavage plus intra-articular corticosteroids in the management of symptomatic osteoarthritis of the knee. Rheumatol 2003; 42: 1477–85.
Peyron JG. Intraarticular hyaluronan injections in the treatment of osteoarthritis: state-of-the-art review. J Rheumatol. 1993;39(suppl):10–5.
Dahlberg L, Lohmander LS, Ryd L. Intraarticular injections of hyaluronan in patients with cartilage abnormalities and knee pain. A one-year double-blind, placebo-controlled study. Arthritis Rheum. 1994;37:521–8.
Henderson EB, Smith EC, Pegley F, Blake DR. Intra-articular injections of 750 kD hyaluronan in the treatment of osteoarthritis: a randomised single centre double-blind placebo-controlled trial of 91 patients demonstrating lack of efficacy. Ann Rheum Dis. 1994;53:529–34.
Lohmander LS, Dalen N, Englund G, Hamalainen M, Jensen EM, Karlsson K, et al. Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomised, double blind, placebo controlled multicentre trial. Hyaluronan Mulicentre Trial Group. Ann Rheum Dis. 1996;55:424–31.
Balazs EA, Denlinger JL. Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol Suppl. Aug 1993;39:3-9.
Dougados M, Nguyen M, Listrat V, Amor B. High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. Osteoarthritis Cart. 1993;1:97–103.
Puhl W, Bernau A, Greiling H, Kopcke W, Pfor-ringer W, Steck KJ, et al. Intraarticular sodium hyaluronate in osteoarthritis of the knee: a multi-centre double-blind study. Osteoarthritis Cart. 1993;1:233–41.
Jones AC, Pattrick M, Doherty S, Doherty M. Intra-articular hyaluronic acid compared to intra-articular triamcinolone hexacetonide in inflammatory knee osteoarthritis. Osteoarthritis Cartilage 1995;3:269–273.
Bannuru RR, Natov NS, Obadan I, et al. Therapeutic Trajectory of Hyaluronic Acid Versus Corticosteroids in the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-Analysis. Arthritis Rheum. 2009 Dec 15;61(12):1704-11.
Caborn D, Rush J, Lanzer W, et al. A randomized, single blind comparison of the efficacy and tolerability of hylan G-F 20 and traimcinolone hexacetonide in patients with osteoarthritis of the knee. J Rheumatol. 2004;31:333-343.
Frizziero I, Pasquali-Ronchetti I. Intra-articula treatment of osteoarthritis of the knee: an arthroscopic and clinical comparison between sodium hyaluronate (500-730 kDa) and methylprednisolone acetate. J Orthop Trauma. 2003:89-96.
Frizziero I, Pasquali-Ronchetti I. Intra-articula treatment of osteoarthritis of the knee: an arthroscopic and clinical comparison between sodium hyaluronate (500-730 kDa) and methylprednisolone acetate. J Orthop Trauma. 2003:89-96.
Jørgensen A, Stengaard-Pedersen K, Simonsen O, et al. Intra-articular hyaluronan is without clinical effect in knee osteoarthritis: a multicentre, randomised, placebo-controlled, double-blind study of 337 patients followed for 1 year. Ann Rheum Dis. 2010 Jun;69(6):1097-102. Epub 2010 May 6.
Jubb RW, Piva S, Beinat L, et al. A one-year randomized placebo (saline) controlled clinical trial of 500-730 kDa sodium hyaluronate (Hyalgan) on the radiological change in osteoarthritis of the knee. Int J Clin Pract. 2003:57(6):467-475.
Petrella RJ. Hyaluronic acid for the treatment of knee osteoarthritis: long-term outcomes from a naturalistic primary care experience. Am J Phys Med Rehabil. 2005 Apr;84(4):278-83; quiz 284, 293.
Tascioglu F, Oner C. Efficacy of intra-articular sodium hyaluronate in the treatment of knee osteoarthritis. Clini Rheumatol. 2003;22:112-117.
Tascioglu F, Oner C. Efficacy of intra-articular sodium hyaluronate in the treatment of knee osteoarthritis. Clini Rheumatol. 2003;22:112-117.
Chevalier X, Jerosch J, Goupille P, et al. Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double- blind, placebo controlled trial. Ann Rheum Dis. 2010 Jan;69(1):113-9.
Altman RD, Akermark C, Beaulieu AD, Schnitzer T. Efficacy and safety of a single intra-articular injection of non-animal stabilized hyaluronic acid (NASHA) in patients with osteoarthritis of the knee. Osteoarthritis Cartilage 2004;12:642–649
Seikagaku announces U.S. FDA approval of Gel-One®, a single injection Hyaluronic Acid injectable treatment for osteoarthritis pain of the knee.Tokyo, Japan, March 24, 2011
Wewers M.E. & Lowe N.K. (1990) A critical review of visual analogue scales in the measurement of clinical phenomena. Research in Nursing and Health 13, 227±236.
Bellamy N Buchanan WW et al. Validation study of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988; 15: 1833-1840.
Bellamy N. Pain assessment in osteoarthritis: Experience with the WOMAC osteoarthritis index. Semin Arthritis Rheumatism. 1989; 18 (supplement 2): 14-17.
Bellamy N Kean WF et al. Double blind randomized controlled trial of sodium meclofenamate (Meclomen) and diclofenac soidum (Voltaren): Post validation reapplication of the WOMAC osteoarthritis index. J Rheumatol. 1992; 19: 153-159.
Hawker G Melfi C et al. Comparison of a generic (SF-36) and a disease specific (WOMAC) instrument in the measurement of outcomes after knee replacement surgery. J Rheumatol. 1995; 22: 1193-1196.
Stucki G Sangha O et al. Comparison of WOMAC (Western Ontario and McMaster Universities) osteoarthritis index and a self-report format of the self-administered Lequesne-Algofunctional index in patients with knee and hip osteoarthritis. Osteoarthritis and Cartilage. 1998; 6: 79-86.
32. Insall JN, Dorr LD, Scott RD, Scott WN. Rationale of the Knee Society clinical rating system. Clin Orthop Relat Res. 1989 Nov;(248):13-4. link to pubmed. Link SF36, SF12
Ann Rheum Dis. 1997 August; 56(8): 493–496.Radiographic osteoarthritis of the knee classified by the Ahlbäck and Kellgren & Lawrence systems for the tibiofemoral joint in people aged 35-54 years with chronic knee pain
Puttick MP, Wade JP, Chalmers A, Connell DG, Rangno KK. Acute local reactions after intraarticular hylan for osteoarthritis of the knee. J Rheumatol. 1995;22:1311-4.
Martens PB. Bilateral symmetric inflammatory reaction to hylan G-F 20 injec- tion. Arthritis Rheum. 2001;44:978-9.
Chen AL, Desai P, Adler EM, Di Cesare PE. Granulomatous inflammation after Hylan G-F 20 viscosupplementation of the knee: a report of six cases. J Bone Joint Surg Am. 2002;84:1142-7.
Leopold SS, Warme WJ, Pettis PD, Shott S. Increased frequency of acute local reaction to intra-articular hylan GF-20 (Synvisc) in patients receiving more than one course of treatment. J Bone Joint Surg Am. 2002;84:1619-23.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2016 The Royal College of Orthopaedic Surgeons of Thailand
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
